Wednesday, April 27, 2016

BRIEF-Molecular Partners posts net loss of 4.2 million Swiss francs in Q1 2016

* Phase II strategy for MP0250 laid-out, strategy about

immuno-oncology pipeline disclosed, business and financial

outlook 2016 fully confirmed

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)